Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
24651 | 305 | 36.3 | 79% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
343 | 3 | NITRIC OXIDE//PEROXYNITRITE//NITRIC OXIDE SYNTHASE | 36678 |
295 | 2 | NITRIC OXIDE//PEROXYNITRITE//NITRIC OXIDE-BIOLOGY AND CHEMISTRY | 18821 |
24651 | 1 | GEA 3175//MESOIONIC 3 ARYL SUBSTITUTED OXATRIAZOLES//NEUTROPHIL DERIVED RELAXING FACTOR | 305 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GEA 3175 | authKW | 278094 | 2% | 56% | 5 |
2 | MESOIONIC 3 ARYL SUBSTITUTED OXATRIAZOLES | authKW | 200231 | 1% | 100% | 2 |
3 | NEUTROPHIL DERIVED RELAXING FACTOR | authKW | 200231 | 1% | 100% | 2 |
4 | CARDIOVASC PHARMACOL UNIT | address | 178771 | 2% | 36% | 5 |
5 | CORONARY ARTERIAL TONE | authKW | 133486 | 1% | 67% | 2 |
6 | NITRIC OXIDE NO RELEASING COMPOUND | authKW | 133486 | 1% | 67% | 2 |
7 | NITRIC OXIDE RELEASING COMPOUNDS | authKW | 128716 | 1% | 43% | 3 |
8 | 2 7 DICHLOROFLUORESEINDIACETATE | authKW | 100115 | 0% | 100% | 1 |
9 | ANTICHYMOTRYPSIN ALPHA1 | authKW | 100115 | 0% | 100% | 1 |
10 | ANTITRYPSIN ALPHA1 | authKW | 100115 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 1254 | 20% | 0% | 61 |
2 | Peripheral Vascular Diseases | 446 | 12% | 0% | 36 |
3 | Pharmacology & Pharmacy | 417 | 23% | 0% | 71 |
4 | Immunology | 271 | 16% | 0% | 48 |
5 | Cell Biology | 200 | 15% | 0% | 45 |
6 | Medicine, Research & Experimental | 111 | 8% | 0% | 25 |
7 | Biochemistry & Molecular Biology | 82 | 18% | 0% | 54 |
8 | Cardiac & Cardiovascular System | 79 | 8% | 0% | 23 |
9 | Physiology | 63 | 6% | 0% | 18 |
10 | Biophysics | 34 | 5% | 0% | 15 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CARDIOVASC PHARMACOL UNIT | 178771 | 2% | 36% | 5 |
2 | AUSTIN HOSP HEMATOL VASC BIOL UNIT | 100115 | 0% | 100% | 1 |
3 | AUSTIN HOSP MED VASC BIOL UNIT | 100115 | 0% | 100% | 1 |
4 | BIZZOZERO PLATELET LEUCOCYTE PHARMACOL | 100115 | 0% | 100% | 1 |
5 | CHIM SPE OMETRIE MASSE BIOORGAN | 100115 | 0% | 100% | 1 |
6 | FOOTHILLS PROV GEN HOSP MED | 100115 | 0% | 100% | 1 |
7 | FOOTHILLS PROV GEN HOSP ONCOL | 100115 | 0% | 100% | 1 |
8 | FOOTHILLS PROV GEN HOSP PEDIAT | 100115 | 0% | 100% | 1 |
9 | INFLAMAT HEMATOL | 100115 | 0% | 100% | 1 |
10 | INSERM UNITE 485 | 100115 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EICOSANOIDS | 3279 | 1% | 2% | 2 |
2 | NITRIC OXIDE-BIOLOGY AND CHEMISTRY | 1830 | 2% | 0% | 5 |
3 | SECOND MESSENGERS AND PHOSPHOPROTEINS | 1667 | 0% | 2% | 1 |
4 | THROMBOSIS RESEARCH | 1638 | 4% | 0% | 13 |
5 | JOURNAL OF LABORATORY AND CLINICAL MEDICINE | 1588 | 3% | 0% | 8 |
6 | BRITISH JOURNAL OF PHARMACOLOGY | 1428 | 5% | 0% | 16 |
7 | JOURNAL OF LEUKOCYTE BIOLOGY | 1426 | 3% | 0% | 10 |
8 | JOURNAL OF INFLAMMATION | 1265 | 0% | 1% | 1 |
9 | CEREBROVASCULAR AND BRAIN METABOLISM REVIEWS | 1234 | 0% | 1% | 1 |
10 | RECEPTOR | 1075 | 0% | 1% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SETHI, S , DIKSHIT, M , (2000) MODULATION OF POLYMORPHONUCLEAR LEUKOCYTES FUNCTION BY NITRIC OXIDE.THROMBOSIS RESEARCH. VOL. 100. ISSUE 3. P. 223 -247 | 54 | 26% | 51 |
2 | ARMSTRONG, R , (2001) THE PHYSIOLOGICAL ROLE AND PHARMACOLOGICAL POTENTIAL OF NITRIC OXIDE IN NEUTROPHIL ACTIVATION.INTERNATIONAL IMMUNOPHARMACOLOGY. VOL. 1. ISSUE 8. P. 1501 -1512 | 35 | 36% | 41 |
3 | RENESTO, P , CHIGNARD, M , (1995) NEUTROPHIL-MEDIATED PLATELET ACTIVATION - A KEY ROLE FOR SERINE PROTEINASES.GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM. VOL. 26. ISSUE 5. P. 905-910 | 23 | 53% | 8 |
4 | YAN, L , VANDIVIER, RW , SUFFREDINI, AF , DANNER, RL , (1994) HUMAN POLYMORPHONUCLEAR LEUKOCYTES LACK DETECTABLE NITRIC-OXIDE SYNTHASE ACTIVITY.JOURNAL OF IMMUNOLOGY. VOL. 153. ISSUE 4. P. 1825-1834 | 26 | 43% | 82 |
5 | KUMARI, R , SINGH, MP , SETH, P , DIKSHIT, M , (1998) INHIBITION OF PLATELET AGGREGATION BY A PROTEIN FACTOR PRESENT IN RAT PERIPHERAL POLYMORPHONUCLEAR LEUKOCYTE SUPERNATANT.THROMBOSIS RESEARCH. VOL. 91. ISSUE 2. P. 75 -82 | 16 | 67% | 2 |
6 | KUMAR, S , JYOTI, A , KESHARI, RS , SINGH, M , BARTHWAL, MK , DIKSHIT, M , (2010) FUNCTIONAL AND MOLECULAR CHARACTERIZATION OF NOS ISOFORMS IN RAT NEUTROPHIL PRECURSOR CELLS.CYTOMETRY PART A. VOL. 77A. ISSUE 5. P. 467-477 | 19 | 33% | 12 |
7 | WANIKIAT, P , WOODWARD, DF , ARMSTRONG, RA , (1997) INVESTIGATION OF THE ROLE OF NITRIC OXIDE AND CYCLIC GMP IN BOTH THE ACTIVATION AND INHIBITION OF HUMAN NEUTROPHILS.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 122. ISSUE 6. P. 1135-1145 | 19 | 43% | 49 |
8 | SHIBATA, K , WARBINGTON, ML , GORDON, BJ , KURIHARA, H , VAN DYKE, TE , (2001) NITRIC OXIDE SYNTHASE ACTIVITY IN NEUTROPHILS FROM PATIENTS WITH LOCALIZED AGGRESSIVE PERIODONTITIS.JOURNAL OF PERIODONTOLOGY. VOL. 72. ISSUE 8. P. 1052 -1058 | 16 | 35% | 19 |
9 | RENESTO, P , BALLOY, V , CHIGNARD, M , (1993) INHIBITION BY HUMAN-LEUKOCYTE ELASTASE OF NEUTROPHIL-MEDIATED PLATELET ACTIVATION.EUROPEAN JOURNAL OF PHARMACOLOGY-ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY SECTION. VOL. 248. ISSUE 2. P. 151-155 | 11 | 69% | 2 |
10 | CHIGNARD, M , HAZOUARD, E , RENESTO, P , LAINE, A , GUIDET, B , OFFENSTADT, G , (1994) PLASMA ANTIPROTEINASE SCREEN AND NEUTROPHIL-MEDIATED PLATELET ACTIVATION - A MAJOR ROLE PLAYED BY ALPHA(1) ANTITRYPSIN.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. VOL. 1224. ISSUE 3. P. 433-440 | 11 | 65% | 10 |
Classes with closest relation at Level 1 |